Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tumescent Analgesia with Lidocaine, Bupivacaine, or Combination for Donor Site Pain After Split-Thickness Skin Graft
TCTR20260503001Phase 3Recruiting
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine, bupivacaine in postoperative pain, sponsored by None. Started Sep 2025; status: recruiting.
02
Drugs
lidocainebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on TCTR20260503001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260503001.